Gary Fanger

Rise Therapeutics, LLC

NIH Rank #918
  • Top 5% Funded
  • Early Career

NIH Funding · FY2024

Total Funding
$5.7M
Fiscal year 2024
Grants Awarded
7
Active NIH grants
National Rank
#918
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $5.7M across 7 grants · National rank #918.

Top grants by award amount

Gary Fanger's NIH grant portfolio, ranked by award amount.

  • 5R44DK137649-02R44
    R-5280, A Novel Modified Superior Resistant Starch Therapy for Type 1 Diabetes
    $995.9K
    award amount
  • 4R44AG084484-02R44
    A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis
    $987.2K
    award amount
  • 5R44AI174332-02R44
    A Novel Synthetic Biology-Derived Microbiome Therapeutic to Treat Viral-Induced Acute Respiratory Distress Syndrome (ARDS)
    $984.4K
    award amount
  • 4R44AI174844-02R44
    A Novel Immunological-Directed Synthetic Biology-Based Drug for the Treatment of Multiple Sclerosis
    $956K
    award amount
  • 5R44DK133061-03R44
    A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis
    $914.7K
    award amount
  • 1SB1DK141356-01SB1
    A Novel Synthetically Engineered Oral Immunotherapy for Treating Ulcerative Colitis
    $673.4K
    award amount
  • 5R44CA261509-04R44
    A Novel Microbiome-Based Immune-Modulator that Potentiates Cancer Checkpoint Therapy
    $171.5K
    award amount

Affiliation

Institutions that have administered grants for Gary Fanger.

Affiliated with Rise Therapeutics, LLC (MD).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Rise Therapeutics, LLC
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #918
  7. 2024
    Entered Top 25% Nationally
    Ranked #918
  8. 2024
    Entered Top 10% Nationally
    Ranked #918
  9. 2024
    Entered Top 5% Nationally
    Ranked #918

Related investigators

Other NIH-funded PIs frequently associated with Gary Fanger.